SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A
about
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.Isoliensinine induces dephosphorylation of NF-kB p65 subunit at Ser536 via a PP2A-dependent mechanism in hepatocellular carcinoma cells: roles of impairing PP2A/I2PP2A interaction.SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen TreatmentCircular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma
P2860
SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@ast
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@en
type
label
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@ast
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@en
prefLabel
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@ast
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@en
P2093
P2860
P356
P1433
P1476
SET antagonist enhances the ch ...... ivating protein phosphatase 2A
@en
P2093
Cheng-Yi Wang
Chung-Wai Shiau
Hui-Chuan Yu
Kuen-Feng Chen
Man-Hsin Hung
Pei-Yi Chu
Ting-Ting Chao
Wei-Tien Tai
Yen-Lin Chen
Yung-Jen Hsiao
P2860
P304
P356
10.18632/ONCOTARGET.6313
P407
P577
2015-11-13T00:00:00Z